PureTech Health PLC PRTC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/13/24 EDT
28.01UNCH (UNCH)
Volume
1,202
52 week range
17.08 - 34.00
Loading...
  • Open28.20
  • Day High28.20
  • Day Low27.52
  • Prev Close27.52
  • 52 Week High34.00
  • 52 Week High Date04/04/24
  • 52 Week Low17.08
  • 52 Week Low Date12/07/23

Key Stats

  • Market Cap757.426M
  • Shares Out27.04M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-2.34

KEY STATS

  • Open28.20
  • Day High28.20
  • Day Low27.52
  • Prev Close27.52
  • 52 Week High34.00
  • 52 Week High Date04/04/24
  • 52 Week Low17.08
  • 52 Week Low Date12/07/23
  • Market Cap757.426M
  • Shares Out27.04M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.19
  • YTD % Change-2.34

RATIOS/PROFITABILITY

  • EPS (TTM)-1.66
  • P/E (TTM)-16.84
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-165.118M
  • ROE (TTM)-8.58%
  • Revenue (TTM)11.738M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-333.47%
  • Debt To Equity (MRQ)4.98%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On PureTech Health PLC

 

Content From Our Affiliates

Profile

MORE
PureTech Health plc is a clinical stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has resulted in the development of around 29 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval....
Raju Kucherlapati Ph.D.
Interim Chairman of the Board, Senior Independent Director
Bharatt Chowrira J.D., Ph.D.
Chief Executive Officer, Director
Eric Elenko Ph.D.
President, Director
Charles Sherwood Ph.D.
General Counsel
Address
6 Tide Street, Suite 400
Boston, MA
02210
United States